Fernando Casafont

2.9k total citations
72 papers, 2.1k citations indexed

About

Fernando Casafont is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Fernando Casafont has authored 72 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 39 papers in Hepatology and 24 papers in Surgery. Recurrent topics in Fernando Casafont's work include Liver Disease Diagnosis and Treatment (25 papers), Liver Disease and Transplantation (24 papers) and Hepatitis C virus research (16 papers). Fernando Casafont is often cited by papers focused on Liver Disease Diagnosis and Treatment (25 papers), Liver Disease and Transplantation (24 papers) and Hepatitis C virus research (16 papers). Fernando Casafont collaborates with scholars based in Spain, United States and Palestinian Territory. Fernando Casafont's co-authors include F. Pons‐Romero, Emilio Fábrega, Javier Crespo, Antonio Cuadrado, M. Prieto, Antoni Rimola, Á. Estébanez, Vı́ctor Vargas, Marta Mayorga and Armando Ruiz and has published in prestigious journals such as New England Journal of Medicine, Hepatology and Neurology.

In The Last Decade

Fernando Casafont

72 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando Casafont Spain 24 1.4k 1.2k 635 240 202 72 2.1k
G. Clemente Spain 32 1.7k 1.3× 2.0k 1.7× 951 1.5× 130 0.5× 166 0.8× 90 2.6k
Stefano Gitto Italy 26 1.2k 0.9× 1.1k 1.0× 486 0.8× 127 0.5× 171 0.8× 83 1.7k
Jeffery L. Steers United States 29 1.0k 0.8× 1.3k 1.1× 1.1k 1.8× 90 0.4× 190 0.9× 64 2.3k
Graeme J.M. Alexander United Kingdom 16 1.2k 0.8× 1.5k 1.3× 673 1.1× 100 0.4× 147 0.7× 27 2.3k
Gonzalo Crespo Spain 22 1.7k 1.2× 1.6k 1.4× 465 0.7× 76 0.3× 93 0.5× 90 2.3k
Anastasios A. Mihas United States 20 1.1k 0.8× 992 0.9× 847 1.3× 190 0.8× 118 0.6× 60 2.1k
Girish Gupte United Kingdom 20 509 0.4× 411 0.4× 736 1.2× 218 0.9× 114 0.6× 109 2.0k
Charles Trey United States 21 802 0.6× 1.1k 0.9× 705 1.1× 136 0.6× 149 0.7× 54 2.0k
Andrea Duchini United States 18 588 0.4× 527 0.5× 328 0.5× 89 0.4× 122 0.6× 30 1.3k
Charalambos G. Antoniades United Kingdom 22 1.0k 0.7× 1.4k 1.2× 477 0.8× 57 0.2× 256 1.3× 30 2.3k

Countries citing papers authored by Fernando Casafont

Since Specialization
Citations

This map shows the geographic impact of Fernando Casafont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Casafont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Casafont more than expected).

Fields of papers citing papers by Fernando Casafont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Casafont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Casafont. The network helps show where Fernando Casafont may publish in the future.

Co-authorship network of co-authors of Fernando Casafont

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Casafont. A scholar is included among the top collaborators of Fernando Casafont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Casafont. Fernando Casafont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fortea, José Ignacio, Antonio Cuadrado, Ángela Puente, et al.. (2020). Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain. Journal of Clinical Medicine. 9(11). 3573–3573. 11 indexed citations
2.
Fortea, José Ignacio, Ángela Puente, Antonio Cuadrado, et al.. (2018). Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey. Digestive and Liver Disease. 51(1). 95–103. 8 indexed citations
3.
Fortea, José Ignacio, Ángela Puente, P. Ruíz, et al.. (2018). Impact of an acute hemodynamic response-guided protocol for primary prophylaxis of variceal bleeding. World Journal of Clinical Cases. 6(13). 611–623. 4 indexed citations
4.
Herrera, Luis, Juan Carlos Rodríguez-Sanjuán, Julio Castillo Diego, et al.. (2009). Traumatic Neuroma of Extrahepatic Bile Ducts After Orthotopic Liver Transplantation. Transplantation Proceedings. 41(3). 1054–1056. 9 indexed citations
5.
Monegal, Ana, Núria Guañabens, María J. Suárez, et al.. (2008). Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial. Transplant International. 22(2). 198–206. 35 indexed citations
6.
7.
Fábrega, Emilio, et al.. (2007). Value of Soluble CD30 in Liver Transplantation. Transplantation Proceedings. 39(7). 2295–2296. 10 indexed citations
8.
Fábrega, Emilio, Aitor Orive, Maria Teresa Garcı́a-Unzueta, et al.. (2006). Osteoprotegerin and receptor activator of nuclear factor‐κB ligand system in the early post‐operative period of liver transplantation. Clinical Transplantation. 20(3). 383–388. 13 indexed citations
9.
Cuadrado, Antonio, Emilio Fábrega, Fernando Casafont, & F. Pons‐Romero. (2005). Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease. Liver Transplantation. 11(4). 420–426. 177 indexed citations
10.
Castro, Beatriz, et al.. (2004). Triple terapia inmunosupresora en el tratamiento de la colitis ulcerosa grave. Gastroenterología y Hepatología. 27(1). 1–5. 4 indexed citations
11.
12.
Rivero, Montserrat, Javier Crespo, Emilio Fábrega, et al.. (2002). Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus. Journal of Viral Hepatitis. 9(2). 107–113. 51 indexed citations
13.
Rivero, Montserrat, et al.. (2002). Involvement of the Fas system in liver allograft rejection. The American Journal of Gastroenterology. 97(6). 1501–1506. 26 indexed citations
14.
Fábrega, Emilio, Javier Crespo, Montserrat Rivero, et al.. (2001). Dendroaspis natriuretic peptide in hepatic cirrhosis. The American Journal of Gastroenterology. 96(9). 2724–2729. 3 indexed citations
15.
Diego, Julio Castillo, Emilio Fábrega, Luis Herrera, et al.. (2001). Liver Transplantation in a Case of Steatohepatitis and Subacute Hepatic Failure after Biliopancreatic Diversion for Morbid Obesity. Obesity Surgery. 11(5). 640–642. 58 indexed citations
16.
Fábrega, Emilio, J. Figols, Carmen Dueñas, et al.. (1997). Value of endothelin in cellular rejection after liver transplantation. Clinical Transplantation. 11(1). 25–28. 4 indexed citations
17.
Fábrega, Emilio, Fernando Casafont, Joaquín de la Peña, et al.. (1997). Nitric oxide production in hepatic cell rejection of liver transplant patients. Transplantation Proceedings. 29(1-2). 505–506. 5 indexed citations
18.
Rimola, Antoni, Joan Manuel Salmerón, G. Clemente, et al.. (1995). Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study. Hepatology. 21(3). 674–679. 131 indexed citations
19.
Polo, J. M., et al.. (1992). Treatment of cerebral aspergillosis after liver transplantation. Neurology. 42(9). 1817–1817. 7 indexed citations
20.
Ginès, Pere, Vicente Arroyo, Vı́ctor Vargas, et al.. (1991). Paracentesis with Intravenous Infusion of Albumin as Compared with Peritoneovenous Shunting in Cirrhosis with Refractory Ascites. New England Journal of Medicine. 325(12). 829–835. 210 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Clemente Breakdown of academic impact, for papers by Stefano Gitto Breakdown of academic impact, for papers by Jeffery L. Steers Breakdown of academic impact, for papers by Graeme J.M. Alexander Breakdown of academic impact, for papers by Gonzalo Crespo Breakdown of academic impact, for papers by Anastasios A. Mihas Breakdown of academic impact, for papers by Girish Gupte Breakdown of academic impact, for papers by Charles Trey Breakdown of academic impact, for papers by Andrea Duchini Breakdown of academic impact, for papers by Charalambos G. Antoniades
Rankless by CCL
2026